FROM THE FOUNDATION

Big Business, Little Data

A growing number of Californians are being sent to ambulatory surgery centers for a wide variety of procedures, yet little is known about the care they deliver because reporting is not required.

And the Winner Is...

See how human-centered designers answered our challenge to encourage more people to complete advance directives and document their end-of-life wishes.

Ready or Not

Even with new federal resources to help, a study finds that communities with weaker safety-net systems are lagging in preparations for health reform.

Prescription Drugs

Thursday, July 05, 2012

DOJ: Glaxo Settles Rx Drug Marketing Lawsuit for $3B

On Monday, the U.S. Department of Justice announced a $3 billion settlement agreement with GlaxoSmithKline to resolve allegations that the British drugmaker broke U.S. laws in marketing several products. Under the agreement, GSK will pay the settlement and plead guilty to misdemeanor criminal charges for illegally marketing antidepressants Paxil and Wellbutrin and for failing to report the safety data on diabetes drug Avandia. The agreement is said to be the largest health care fraud settlement in U.S. history.



Readers are invited to send feedback to: chl@chcf.org